Business Wire

Global Audiobook Publishing House “ABP Publishing” Achieves a 25% Revenue Increase in 2022 through Dual-Focus Production and Promotion Strategy

1.5.2023 12:00:00 EEST | Business Wire | Press release

Share

ABP Publishing, the global audiobook publisher, reports a 25% increase in revenue for 2022 compared to the previous year. The company achieved this through a dual-focus production and promotion strategy, investing heavily in marketing and increasing publication volumes through remote production methods. The publisher reached 95% of its target audience in transnational markets, including avid audiobook enthusiasts.

ABP Publishing expanded its portfolio to over 460 audiobooks in 2022, resulting in a 30% increase in its catalog. The company strategically developed remote production, which included translation, edition, and narration, regardless of geographical location. This strategy required the hiring of more editors and voice actors on staff. Additionally, this approach enabled the company to double its Turkish-language catalog.

In addition, ABP Publishing not only introduced bestselling authors to new markets but also added new writers to its list of published works. Notable authors such as Robert Kiyosaki in Italy, Benjamin Graham in both Italy and France, Jordan Peterson, Bessel Van der Kolk, and Will Smith in France, Wim Hof in Germany have been published by ABP Publishing.

The company's audiobook promotion reached 2 million enthusiasts on various platforms, resulting in top 100 chart rankings on Audible and Storytel. ABP Publishing held 15% of the top 100 in Audible Books & Originals and 5-7% in Italy's Audible and 10% on Storytel in Turkey. ABP Publishing's books consistently ranked in the top 10 in categories such as "Psychology", "Career", "Self-improvement", "Health", and "Financial Management".

"ABP Publishing has managed to implement a new remote audiobook production approach successfully," claims Viktoria Salnikova, Chief Editor of ABP Publishing. "We have been able to increase production volumes without compromising on quality, which is one of our top priorities."

"We are dedicated to promoting our audiobooks in developing markets as part of our unified strategy for market penetration," says Andrey Mishenev, CEO of ABP Publishing. "We are pleased with the success we have achieved, resulting in increased production volumes. For 2023, our mission is to provide readers with the wisdom of hundreds of the most revered authors, delivering classic nonfiction titles and the best new releases in audiobooks to inspire and cultivate a more enlightened culture among readers."

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contact Information:

Media Relations
ABP PUBLISHING LTD
Email: info@abp-publishing.com
Website: https://abp-publishing.com/
Andrey Mishenev, +357 94 203545

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GenBio AI Builds First World Model of the Human Cell18.8.2026 16:00:00 EEST | Press release

GenBio AI ('GenBio') is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute, and other research institutions. Today, the company introduced AIDO Cell, its virtual cell world model — the first system capable of simulating a human cell, both in its natural state and in response to drugs and other interventions, across its full biological hierarchy, from DNA and RNA through protein to the whole-cell level. A Key First in Biological and Medical Sciences: Full-hierarchy virtual cell simulation has been widely identified as a key milestone in computational biology. Compared to the previous efforts by various research labs, AIDO Cell is the first to integrate the entire molecular-to-cellular spectrum into one continuous simulation. Using the system

Xsolla Partner Network Expands Verified Creator Partnerships and Unifies Campaign Management Ahead of gamescom 202618.8.2026 16:00:00 EEST | Press release

Xsolla, a global video game commerce company, today announced an expansion of the Xsolla Partner Network ahead of gamescom 2026 in Cologne, giving game developers a simpler, more reliable way to grow their games through creators. The creator platform now lives within Xsolla Publisher Account, where developers already run their business, with verified creator onboarding and a redesigned and unified campaign workflow. Flat-fee campaigns, a new guaranteed payment option alongside revenue share, and data-driven creator recommendations are coming soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818140062/en/ Graphic: Xsolla Xsolla Partner Network gives developers one place to launch, manage, track, and report on creator campaigns while Xsolla handles payments, payouts, taxes, and compliance. Verified creators, less guesswork. Automated anti-fraud vetting and identity verification at payout means developers partner with rea

KOCCA to Showcase 13 Korean Game Companies at ‘Gamescom 2026’ with PC, Mobile, and VR Lineups18.8.2026 15:48:00 EEST | Press release

The Korea Creative Content Agency (KOCCA) announced that 13 Korean game companies will gather under one roof at Gamescom 2026, Europe’s largest game show, held in Cologne, Germany, from August 26 to 28 (B2B, 09:00~20:00). Located in Booth Hall 3.2 C-050g–D051g, the Korea Joint Pavilion offers visitors hands-on experiences with an expansive lineup of titles, ranging from PC and mobile games to VR-powered titles across diverse genres. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818271881/en/ KOCCA will bring 13 Korean game companies to Gamescom 2026 in Cologne, Germany (Image: KOCCA) The standout feature of this year’s joint pavilion is its overwhelming genre diversity. The lineup includes roguelike deckbuilders, visual novels, 2D shooters, rhythm action, and cooperative horror survival—catering to a broad spectrum of gamers—alongside immersive content that integrates AI and XR technology. Introducing the Participating T

SLB to Support Offshore Production Restoration for Brunei Shell Petroleum18.8.2026 15:06:00 EEST | Press release

Global energy technology company SLB (NYSE: SLB) today announced it has been awarded a contract by Brunei Shell Petroleum (BSP) to support production restoration from shut-in wells across multiple offshore fields. The contract scope spans subsurface evaluation, well candidate selection, engineering and offshore execution. Project management, intervention services, monitoring, metering and marine logistics are integrated within a single coordinated execution model designed to support efficient production restoration. “Building on our long collaboration in the region, this contract reflects a shared commitment to maximizing value from existing offshore resources,” said Gokhan Yarim, senior vice president of Integration, SLB. “Together with BSP, we are combining SLB’s production expertise and integrated execution capabilities to help restore production from shut-in wells, increase recovery from existing infrastructure and support BSP’s long-term production objectives.” The project marks t

BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries18.8.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership through 2028 to expand access to BRUKINSA® (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively. Building on a collaboration launched in 2023, the renewed partnership reflects the organizations’ shared commitment to improving access to innovative cancer treatments in underserved communities. To date, the partnership has enabled access to BRUKINSA for more than 300 patients with CLL across Armenia, Ethiopia, and Nepal, exceeding the program’s original scope by approximately 150 patients and helping establish access to innovative cancer care for patients who previo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye